HEADER TRANSFERASE 12-JAN-06 2FO0
TITLE ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE
TITLE 2 C-ABL TYROSINE KINASE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1 (1B ISOFORM);
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: ABL N-CAP (RESIDUES 1-531, RESIDUES 15-56 DELETED);
COMPND 5 EC: 2.7.1.112;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: C-ABL;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1
KEYWDS N-TERMINAL CAP, AUTOINHIBITION, MYRISTOYLATION, SH3-SH2 CLAMP,
KEYWDS 2 PHOSPHOSERINE, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR B.NAGAR,O.HANTSCHEL,M.SEELIGER,J.M.DAVIES,W.I.WEIS,G.SUPERTI-FURGA,
AUTHOR 2 J.KURIYAN
REVDAT 9 30-OCT-24 2FO0 1 REMARK
REVDAT 8 30-AUG-23 2FO0 1 REMARK
REVDAT 7 20-OCT-21 2FO0 1 SEQADV
REVDAT 6 30-JUN-21 2FO0 1 REMARK SEQADV LINK ATOM
REVDAT 5 02-AUG-17 2FO0 1 SOURCE
REVDAT 4 13-JUL-11 2FO0 1 VERSN
REVDAT 3 24-FEB-09 2FO0 1 VERSN
REVDAT 2 04-APR-06 2FO0 1 AUTHOR
REVDAT 1 21-MAR-06 2FO0 0
JRNL AUTH B.NAGAR,O.HANTSCHEL,M.SEELIGER,J.M.DAVIES,W.I.WEIS,
JRNL AUTH 2 G.SUPERTI-FURGA,J.KURIYAN
JRNL TITL ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE
JRNL TITL 2 FORMS OF THE C-ABL TYROSINE KINASE.
JRNL REF MOL.CELL V. 21 787 2006
JRNL REFN ISSN 1097-2765
JRNL PMID 16543148
JRNL DOI 10.1016/J.MOLCEL.2006.01.035
REMARK 2
REMARK 2 RESOLUTION. 2.27 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.14
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 318702.330
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.3
REMARK 3 NUMBER OF REFLECTIONS : 24283
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.210
REMARK 3 FREE R VALUE : 0.246
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.800
REMARK 3 FREE R VALUE TEST SET COUNT : 1656
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.50
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3000
REMARK 3 BIN R VALUE (WORKING SET) : 0.2700
REMARK 3 BIN FREE R VALUE : 0.2800
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.30
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 235
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3748
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 56
REMARK 3 SOLVENT ATOMS : 145
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 17.20
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.80
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -9.32000
REMARK 3 B22 (A**2) : -10.46000
REMARK 3 B33 (A**2) : 19.77000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27
REMARK 3 ESD FROM SIGMAA (A) : 0.35
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.580 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.680 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.230 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.400 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.38
REMARK 3 BSOL : 33.70
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : LIGANDS.PAR
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN_REP.TOP
REMARK 3 TOPOLOGY FILE 2 : LIGANDS.TOP
REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2FO0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-06.
REMARK 100 THE DEPOSITION ID IS D_1000036103.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 24-SEP-03
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 8.2.2
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.1
REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25639
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270
REMARK 200 RESOLUTION RANGE LOW (A) : 48.140
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5
REMARK 200 DATA REDUNDANCY : 4.100
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.09500
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35
REMARK 200 COMPLETENESS FOR SHELL (%) : 76.5
REMARK 200 DATA REDUNDANCY IN SHELL : 2.50
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.28900
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 1OPK
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.78
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 10000, 0.1M HEPES, PH 7.5,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.84400
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.63300
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.84400
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.63300
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 GLY A 2
REMARK 465 GLN A 3
REMARK 465 GLN A 4
REMARK 465 PRO A 5
REMARK 465 GLY A 6
REMARK 465 LYS A 7
REMARK 465 VAL A 8
REMARK 465 LEU A 9
REMARK 465 GLY A 10
REMARK 465 ASP A 11
REMARK 465 GLN A 12
REMARK 465 ARG A 13
REMARK 465 ARG A 14
REMARK 465 GLU A 57
REMARK 465 PRO A 58
REMARK 465 GLN A 59
REMARK 465 GLY A 60
REMARK 465 LEU A 61
REMARK 465 SER A 62
REMARK 465 GLU A 63
REMARK 465 ALA A 64
REMARK 465 LYS A 531
REMARK 465 GLU A 532
REMARK 465 ASN A 533
REMARK 465 LEU A 534
REMARK 465 TYR A 535
REMARK 465 GLY A 536
REMARK 465 GLN A 537
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 77 C - N - CA ANGL. DEV. = 11.2 DEGREES
REMARK 500 PRO A 82 C - N - CA ANGL. DEV. = 11.9 DEGREES
REMARK 500 PRO A 82 C - N - CD ANGL. DEV. = -14.5 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 TRP A 67 76.61 -106.09
REMARK 500 SEP A 69 25.96 -78.09
REMARK 500 ASP A 226 60.49 38.86
REMARK 500 ARG A 239 -70.08 -47.15
REMARK 500 ASP A 252 68.89 35.79
REMARK 500 LYS A 253 56.58 -114.03
REMARK 500 LYS A 264 -145.76 -123.32
REMARK 500 ASP A 295 -8.19 -59.68
REMARK 500 MET A 297 77.59 -68.74
REMARK 500 HIS A 380 -60.91 -101.49
REMARK 500 ARG A 381 -3.96 80.44
REMARK 500 ASP A 400 43.06 -95.45
REMARK 500 ASP A 410 160.01 176.92
REMARK 500 TRP A 495 30.57 -96.58
REMARK 500 LEU A 529 -62.35 -91.46
REMARK 500
REMARK 500 REMARK: NULL
REMARK 610
REMARK 610 MISSING HETEROATOM
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 610 I=INSERTION CODE):
REMARK 610 M RES C SSEQI
REMARK 610 MYR A 701
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR A 701
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P16 A 702
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 703
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 704
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 RESIDUES 15-56 OF THE ORIGINAL PROTEIN SEQUENCE WERE
REMARK 999 DELETED. MYRISTOYL GROUP (MYR) IS COVALENTLY ATTACHED TO THE
REMARK 999 N-TERMINUS OF THE PROTEIN.
DBREF 2FO0 A 1 14 UNP P00519-2 ABL1_HUMAN 1 14
DBREF 2FO0 A 57 531 UNP P00519-2 ABL1_HUMAN 57 531
SEQADV 2FO0 SEP A 69 UNP P00519-2 SER 69 MODIFIED RESIDUE
SEQADV 2FO0 ASN A 382 UNP P00519-2 ASP 382 ENGINEERED MUTATION
SEQADV 2FO0 GLU A 532 UNP P00519-2 CLONING ARTIFACT
SEQADV 2FO0 ASN A 533 UNP P00519-2 CLONING ARTIFACT
SEQADV 2FO0 LEU A 534 UNP P00519-2 CLONING ARTIFACT
SEQADV 2FO0 TYR A 535 UNP P00519-2 CLONING ARTIFACT
SEQADV 2FO0 GLY A 536 UNP P00519-2 CLONING ARTIFACT
SEQADV 2FO0 GLN A 537 UNP P00519-2 CLONING ARTIFACT
SEQRES 1 A 495 MET GLY GLN GLN PRO GLY LYS VAL LEU GLY ASP GLN ARG
SEQRES 2 A 495 ARG GLU PRO GLN GLY LEU SER GLU ALA ALA ARG TRP ASN
SEQRES 3 A 495 SEP LYS GLU ASN LEU LEU ALA GLY PRO SER GLU ASN ASP
SEQRES 4 A 495 PRO ASN LEU PHE VAL ALA LEU TYR ASP PHE VAL ALA SER
SEQRES 5 A 495 GLY ASP ASN THR LEU SER ILE THR LYS GLY GLU LYS LEU
SEQRES 6 A 495 ARG VAL LEU GLY TYR ASN HIS ASN GLY GLU TRP CYS GLU
SEQRES 7 A 495 ALA GLN THR LYS ASN GLY GLN GLY TRP VAL PRO SER ASN
SEQRES 8 A 495 TYR ILE THR PRO VAL ASN SER LEU GLU LYS HIS SER TRP
SEQRES 9 A 495 TYR HIS GLY PRO VAL SER ARG ASN ALA ALA GLU TYR LEU
SEQRES 10 A 495 LEU SER SER GLY ILE ASN GLY SER PHE LEU VAL ARG GLU
SEQRES 11 A 495 SER GLU SER SER PRO GLY GLN ARG SER ILE SER LEU ARG
SEQRES 12 A 495 TYR GLU GLY ARG VAL TYR HIS TYR ARG ILE ASN THR ALA
SEQRES 13 A 495 SER ASP GLY LYS LEU TYR VAL SER SER GLU SER ARG PHE
SEQRES 14 A 495 ASN THR LEU ALA GLU LEU VAL HIS HIS HIS SER THR VAL
SEQRES 15 A 495 ALA ASP GLY LEU ILE THR THR LEU HIS TYR PRO ALA PRO
SEQRES 16 A 495 LYS ARG ASN LYS PRO THR VAL TYR GLY VAL SER PRO ASN
SEQRES 17 A 495 TYR ASP LYS TRP GLU MET GLU ARG THR ASP ILE THR MET
SEQRES 18 A 495 LYS HIS LYS LEU GLY GLY GLY GLN TYR GLY GLU VAL TYR
SEQRES 19 A 495 GLU GLY VAL TRP LYS LYS TYR SER LEU THR VAL ALA VAL
SEQRES 20 A 495 LYS THR LEU LYS GLU ASP THR MET GLU VAL GLU GLU PHE
SEQRES 21 A 495 LEU LYS GLU ALA ALA VAL MET LYS GLU ILE LYS HIS PRO
SEQRES 22 A 495 ASN LEU VAL GLN LEU LEU GLY VAL CYS THR ARG GLU PRO
SEQRES 23 A 495 PRO PHE TYR ILE ILE THR GLU PHE MET THR TYR GLY ASN
SEQRES 24 A 495 LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG GLN GLU VAL
SEQRES 25 A 495 ASN ALA VAL VAL LEU LEU TYR MET ALA THR GLN ILE SER
SEQRES 26 A 495 SER ALA MET GLU TYR LEU GLU LYS LYS ASN PHE ILE HIS
SEQRES 27 A 495 ARG ASN LEU ALA ALA ARG ASN CYS LEU VAL GLY GLU ASN
SEQRES 28 A 495 HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SER ARG LEU
SEQRES 29 A 495 MET THR GLY ASP THR TYR THR ALA HIS ALA GLY ALA LYS
SEQRES 30 A 495 PHE PRO ILE LYS TRP THR ALA PRO GLU SER LEU ALA TYR
SEQRES 31 A 495 ASN LYS PHE SER ILE LYS SER ASP VAL TRP ALA PHE GLY
SEQRES 32 A 495 VAL LEU LEU TRP GLU ILE ALA THR TYR GLY MET SER PRO
SEQRES 33 A 495 TYR PRO GLY ILE ASP LEU SER GLN VAL TYR GLU LEU LEU
SEQRES 34 A 495 GLU LYS ASP TYR ARG MET GLU ARG PRO GLU GLY CYS PRO
SEQRES 35 A 495 GLU LYS VAL TYR GLU LEU MET ARG ALA CYS TRP GLN TRP
SEQRES 36 A 495 ASN PRO SER ASP ARG PRO SER PHE ALA GLU ILE HIS GLN
SEQRES 37 A 495 ALA PHE GLU THR MET PHE GLN GLU SER SER ILE SER ASP
SEQRES 38 A 495 GLU VAL GLU LYS GLU LEU GLY LYS GLU ASN LEU TYR GLY
SEQRES 39 A 495 GLN
MODRES 2FO0 SEP A 69 SER PHOSPHOSERINE
HET SEP A 69 10
HET MYR A 701 15
HET P16 A 702 29
HET GOL A 703 6
HET GOL A 704 6
HETNAM SEP PHOSPHOSERINE
HETNAM MYR MYRISTIC ACID
HETNAM P16 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)
HETNAM 2 P16 PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
HETNAM GOL GLYCEROL
HETSYN SEP PHOSPHONOSERINE
HETSYN P16 PD166326
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 1 SEP C3 H8 N O6 P
FORMUL 2 MYR C14 H28 O2
FORMUL 3 P16 C21 H16 CL2 N4 O2
FORMUL 4 GOL 2(C3 H8 O3)
FORMUL 6 HOH *145(H2 O)
HELIX 1 1 TRP A 67 LEU A 73 5 7
HELIX 2 2 GLY A 76 ASN A 80 5 5
HELIX 3 3 SER A 140 HIS A 144 5 5
HELIX 4 4 SER A 152 LEU A 160 1 9
HELIX 5 5 THR A 213 VAL A 224 1 12
HELIX 6 6 GLU A 257 THR A 259 5 3
HELIX 7 7 GLY A 268 GLN A 271 5 4
HELIX 8 8 LYS A 282 SER A 284 5 3
HELIX 9 9 GLU A 298 ILE A 312 1 15
HELIX 10 10 ASN A 341 CYS A 349 1 9
HELIX 11 11 ASN A 355 LYS A 376 1 22
HELIX 12 12 ALA A 384 ARG A 386 5 3
HELIX 13 13 GLU A 392 HIS A 394 5 3
HELIX 14 14 PRO A 421 THR A 425 5 5
HELIX 15 15 ALA A 426 ASN A 433 1 8
HELIX 16 16 SER A 436 THR A 453 1 18
HELIX 17 17 ASP A 463 LYS A 473 1 11
HELIX 18 18 PRO A 484 TRP A 495 1 12
HELIX 19 19 ASN A 498 ARG A 502 5 5
HELIX 20 20 SER A 504 THR A 514 1 11
HELIX 21 21 SER A 520 GLY A 530 1 11
SHEET 1 A 5 GLY A 126 PRO A 131 0
SHEET 2 A 5 TRP A 118 THR A 123 -1 N ALA A 121 O GLY A 128
SHEET 3 A 5 LYS A 106 TYR A 112 -1 N GLY A 111 O GLU A 120
SHEET 4 A 5 PHE A 85 ALA A 87 -1 N PHE A 85 O LEU A 107
SHEET 5 A 5 ILE A 135 PRO A 137 -1 O THR A 136 N VAL A 86
SHEET 1 B 5 TYR A 147 PRO A 150 0
SHEET 2 B 5 SER A 167 GLU A 172 1 O VAL A 170 N HIS A 148
SHEET 3 B 5 ARG A 180 TYR A 186 -1 O ARG A 185 N SER A 167
SHEET 4 B 5 ARG A 189 THR A 197 -1 O TYR A 191 N LEU A 184
SHEET 5 B 5 LEU A 203 TYR A 204 -1 O TYR A 204 N ASN A 196
SHEET 1 C 3 TYR A 147 PRO A 150 0
SHEET 2 C 3 SER A 167 GLU A 172 1 O VAL A 170 N HIS A 148
SHEET 3 C 3 TYR A 234 PRO A 235 1 O TYR A 234 N PHE A 168
SHEET 1 D 5 ILE A 261 LYS A 266 0
SHEET 2 D 5 VAL A 275 TRP A 280 -1 O GLU A 277 N HIS A 265
SHEET 3 D 5 LEU A 285 THR A 291 -1 O LEU A 285 N TRP A 280
SHEET 4 D 5 TYR A 331 GLU A 335 -1 O ILE A 332 N LYS A 290
SHEET 5 D 5 LEU A 320 CYS A 324 -1 N LEU A 321 O ILE A 333
SHEET 1 E 2 PHE A 378 ILE A 379 0
SHEET 2 E 2 SER A 404 ARG A 405 -1 O SER A 404 N ILE A 379
SHEET 1 F 2 CYS A 388 VAL A 390 0
SHEET 2 F 2 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389
SHEET 1 G 2 TYR A 412 THR A 413 0
SHEET 2 G 2 LYS A 434 PHE A 435 -1 O PHE A 435 N TYR A 412
LINK C ASN A 68 N SEP A 69 1555 1555 1.33
LINK C SEP A 69 N LYS A 70 1555 1555 1.33
CISPEP 1 PRO A 328 PRO A 329 0 -0.35
SITE 1 AC1 2 GLU A 481 ILE A 521
SITE 1 AC2 14 TYR A 272 VAL A 275 ALA A 288 LYS A 290
SITE 2 AC2 14 GLU A 305 MET A 309 THR A 334 GLU A 335
SITE 3 AC2 14 PHE A 336 MET A 337 GLY A 340 LEU A 389
SITE 4 AC2 14 ALA A 399 ASP A 400
SITE 1 AC3 5 TYR A 345 GLY A 391 GLU A 392 ASN A 393
SITE 2 AC3 5 HIS A 394
SITE 1 AC4 4 THR A 197 ALA A 198 THR A 296 MET A 297
CRYST1 79.688 117.266 60.416 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012549 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008528 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016552 0.00000